| Name | Title | Contact Details |
|---|
Providing the world`s best healthcare to everyone
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
Founded in 1961, APDA is the nations largest grassroots network dedicated to assist the more than 1 million Americans living with Parkinson’s disease.
Innovagraft Biologics is a Wayzata, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VisionShare Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.